We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Tenet Healthcare
THC
$20.9B
| $19.5M | 0.04% |
371,644
+122,632
| +49% | +$8.53M |
|
502
A.O. Smith
AOS
$8.48B
| $19.5M | 0.04% |
362,561
-94,768
| -21% | -$5.69M |
|
503
KeyCorp
KEY
$24.3B
| $19.5M | 0.04% |
1,157,600
+265,850
| +30% | +$5.14M |
|
504
Atmos Energy
ATO
$28.4B
| $19.3M | 0.04% |
174,129
+18,842
| +12% | +$2.16M |
|
505
Royal Gold
RGLD
$19.8B
| $19.3M | 0.04% |
180,657
+125,368
| +227% | +$15.5M |
|
|
SNV
506
DELISTED
Synovus
SNV
| $19.3M | 0.04% |
546,546
+210,511
| +63% | +$8.71M |
|
507
ZTO Express
ZTO
$18.2B
| $19.2M | 0.04% |
699,434
-3,184
| -0.5% | -$81.6K |
|
508
Semtech
SMTC
$12.2B
| $19.1M | 0.04% |
352,614
+169,863
| +93% | +$10.2M |
|
509
Sabra Healthcare REIT
SBRA
$5.28B
| $19.1M | 0.04% |
1,363,844
-383,213
| -22% | -$5.12M |
|
510
Coty
COTY
$2.51B
| $19M | 0.04% |
2,463,636
+1,185,189
| +93% | +$8.9M |
|
511
Ameriprise Financial
AMP
$49.2B
| $19M | 0.04% |
81,452
-41,927
| -34% | -$11.2M |
|
512
Freeport-McMoran
FCX
$98.7B
| $18.9M | 0.04% |
647,277
+273,955
| +73% | +$11M |
|
513
Cencora
COR
$62B
| $18.9M | 0.04% |
133,747
-157,767
| -54% | -$24.1M |
|
|
JBGS
514
JBG SMITH
JBGS
$653M
| $18.9M | 0.04% |
802,454
+130,733
| +19% | +$3.38M |
|
515
Fidelity National Information Services
FIS
$21.9B
| $18.8M | 0.04% |
208,188
+1,183
| +0.6% | +$118K |
|
516
Infosys
INFY
$50.9B
| $18.8M | 0.04% |
1,016,971
-5,027,354
| -83% | -$100M |
|
517
Graham Holdings Company
GHC
$4.99B
| $18.7M | 0.04% |
33,262
+676
| +2% | +$402K |
|
518
Hawaiian Electric Industries
HE
$2.02B
| $18.5M | 0.04% |
456,636
+30,609
| +7% | +$1.29M |
|
519
KB Home
KBH
$3.47B
| $18.5M | 0.04% |
669,729
+409,273
| +157% | +$13.1M |
|
520
Energizer
ENR
$1.5B
| $18.5M | 0.04% |
661,729
+227,071
| +52% | +$6.83M |
|
521
BJs Wholesale Club
BJ
$12.3B
| $18.5M | 0.04% |
299,050
+87,343
| +41% | +$5.49M |
|
522
Thor Industries
THO
$4.14B
| $18.4M | 0.04% |
248,492
+145,134
| +140% | +$11.3M |
|
523
Reynolds Consumer Products
REYN
$5.51B
| $18.3M | 0.04% |
682,305
+76,402
| +13% | +$2.14M |
|
524
Equity Residential
EQR
$24.7B
| $18.3M | 0.04% |
256,253
+10,517
| +4% | +$834K |
|
525
PayPal
PYPL
$50.5B
| $18.3M | 0.04% |
269,510
+63,735
| +31% | +$5.53M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.